Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Former Roche Exec To Lead AstraZeneca
by Ann M. Thayer
September 3, 2012
| A version of this story appeared in
Volume 90, Issue 36
Pascal Soriot, former head of Roche’s pharmaceutical division, has been named AstraZeneca’s new CEO. He will join AstraZeneca on Oct. 1, and interim CEO Simon Lowth will return to his role as chief financial officer. Prior to starting his now 26-year career in the drug industry, Soriot, 53, was a practicing veterinarian. Meanwhile, effective Sept. 1, Daniel O’Day will lead Roche Pharma and Roland Diggelmann will succeed him as head of Roche Diagnostics.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X